फ्लुटिकासोन और सैल्मेटेरोल और टियोट्रोपियम का इंटरैक्शन

Concomitant Respiratory Medications SPIRIVA RESPIMAT has been used concomitantly with short-acting and long-acting sympathomimetic (beta-agonists) bronchodilators, methylxanthines, oral and inhaled steroids, antihistamines, mucolytics, leukotriene modifiers, cromones, and anti-IgE treatment without increases in adverse reactions.

In the event of an acute attack, a rapid-acting beta 2 -agonist should be used.

If this occurs, it should be treated immediately with an inhaled short-acting beta 2 -agonist such as albuterol.

If paradoxical bronchospasm occurs following dosing with inhaled fluticasone propionate/salmeterol medicines, it should be treated immediately with an inhaled, short-acting bronchodilator; inhaled fluticasone propionate/salmeterol medicines should be discontinued immediately; and alternative therapy should be instituted.